← Back to Search

iTransition App for Youth with HIV

N/A
Waitlist Available
Led By Sophia Hussen, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-year post-intervention
Awards & highlights

Study Summary

This trial will develop a mobile app to help both clinical providers and patients navigate the process of transitioning from pediatric to adult care for youth living with HIV.

Who is the study for?
This trial is for young adults living with HIV who are about to switch from pediatric to adult care. Participants must be over 18, planning healthcare transition (HCT) within 6 months, and receiving care at specific clinics. They should own a smartphone or tablet with consistent internet access. Healthcare providers involved in HCT can also participate.Check my eligibility
What is being tested?
The trial is developing 'iTransition', a mobile app designed to support youth living with HIV and their clinical providers during the critical shift from pediatric to adult healthcare services.See study design
What are the potential side effects?
Since this intervention involves using a mobile app rather than medication, traditional side effects are not expected. However, users may experience stress or anxiety related to technology use or reminders of their health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-year post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-year post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Linkage to adult care
Secondary outcome measures
Change in Care retention
Change in viral suppression

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: YLH iTransition Intervention GroupExperimental Treatment1 Intervention
Participants in this group will have the following phases: Screening Baseline Visit Follow-Up visits at 6, 12 and 18 month Interview visits for selected YLH around 3 and 9 month
Group II: Transition Champion GroupExperimental Treatment1 Intervention
Participants in this group will have the following phases: Screening Baseline Visit and Follow-Up visits at 6, 12 and 18 month Interview visits for selected YLH around 3, 9 and 15 month
Group III: Provider GroupExperimental Treatment1 Intervention
Participants in this group will have the following phases: Screening Baseline Visit Follow-Up visits at 6, 12 and 18 month Interview visits for selected YLH around 3, 9 and 15 month
Group IV: YLH Historical Control GroupActive Control1 Intervention
Participants in this group will have the following phases: Screening Single visit assessment

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,778 Previous Clinical Trials
2,674,476 Total Patients Enrolled
Emory UniversityLead Sponsor
1,635 Previous Clinical Trials
2,560,112 Total Patients Enrolled
Sophia Hussen, MDPrincipal Investigator - Emory University
Emory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
iTransition Development
Sophia Hussen 2020. "iTransition Development". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04383223.
All > Hiv > Aids
~2 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top